Q32 Bio, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7469641051
USD
12.85
5.76 (81.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Q32 Bio, Inc.

Why is Q32 Bio, Inc. ?

1
The company has declared Positive results for the last 4 consecutive quarters
  • NET PROFIT(HY) Higher at USD 50.12 MM
  • ROCE(HY) Highest at 157.18%
  • RAW MATERIAL COST(Y) Fallen by 0% (YoY)
2
With ROE of 215.73%, it has a attractive valuation with a -5.00 Price to Book Value
  • Over the past year, while the stock has generated a return of 664.88%, its profits have risen by 47.4%
3
High Institutional Holdings at 83%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
  • Along with generating 664.88% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Q32 Bio, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
10.60%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
98.51%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-5.00
EV to EBIT
-1.26
EV to EBITDA
-1.28
EV to Capital Employed
-0.99
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
NET PROFIT(HY)

Higher at USD 50.12 MM

ROCE(HY)

Highest at 157.18%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

NET SALES(9M)

Higher at USD 53.74 MM

-9What is not working for the Company
PRE-TAX PROFIT(Q)

At USD -7.61 MM has Fallen at -195.35%

NET PROFIT(Q)

At USD -7.61 MM has Fallen at -195.35%

INTEREST(HY)

At USD 0.4 MM has Grown at 33.33%

CASH AND EQV(HY)

Lowest at USD 99.05 MM

Here's what is working for Q32 Bio, Inc.

Net Sales
At USD 53.74 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Net Sales
Higher at USD 53.74 MM
than preceding 12 month period ended Mar 2026
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Q32 Bio, Inc.

Pre-Tax Profit
At USD -7.61 MM has Fallen at -195.35%
over average net sales of the previous four periods of USD 7.98 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -7.61 MM has Fallen at -195.35%
over average net sales of the previous four periods of USD 7.98 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest
At USD 0.4 MM has Grown at 33.33%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Cash and Eqv
Lowest at USD 99.05 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents